Thrombo-embolic complications related to hormone therapy of breast cancer - a case report
Journal Title: OncoReview - Year 2013, Vol 3, Issue 1
Abstract
69-year old female with breast cancer treated with surgery (total mastectomy) and cheamo- and radiotherapy, with cancer in right breast operated last year, with further hormone therapy with tamoxifen, suffered from low risk pulmonary embolism. She was treated with streptokinase which was complicated by intracerebral bleeding. The patient was referred to the neurosurgeon and conservative treatment was ordered. Than she was transferred to Department of Pulmonary Circulation and Thromboembolic Diseases, ECZ Otwock where vena cava filter was implanted as prevention of recurrence pulmonary embolism. Progression of deep venous thrombosis associated with thrombosis in vena cava filter and the ”resistance” to treatment using enoxaparin was observed. The inclusion of unfractionated heparin in continuous intravenous infusion, withdrawal of tamoxifen and intensification diuretic therapy has improved patient’s status and allowed discharge from hospital.
Authors and Affiliations
Szymon Darocha, Sebastian Szmit, Łukasz Kownacki, Marcin Kurzyna
Cardiac amyloidosis: a hidden cause of cardiovascular complications in oncology practice
Amyloidosis is rare, but known cause of heart failure, cardiomyopathy, coronary artery disease, disorders of cardiac conduction system and valvular damage. Disease often remains undetected until it reaches an advanced st...
Advanced skin melanoma – systemic treatment
In Poland, morbidity and mortality rates for melanoma are constantly increasing. In the case of inoperable disease or distant metastases, prognosis remains poor. For many years, dacarbazine has been the gold standard in...
Fertility and breast cancer
Breast cancer is the most common cancer among females worldwide. The mean age of breast cancer patients is > 60 yrs old, and it is seldom found in women < 40 yrs old (6.5%) and in very young women < 35 yrs old (0.6%). In...
Zespół rozpadu guza
Zespół rozpadu guza jest stanem zagrożenia życia występującym u pacjentów z rozległymi nowotworami, u których pod wpływem chemioterapii bądź samoistnie dochodzi do masywnego rozpadu komórek nowotworowych z uwolnieniem ic...
Cardiooncological balance in a 75-year-old male with a hepatocellular carcinoma CS IV and a congestive heart failure NYHA III „de novo”
The case reports about a 75-years-old man without a previous medical history, in whom a heart failure NYHA III de novo was diagnosed together with persistent atrial fibrillation and hepatocellular carcinoma in clinical s...